Open-label, Two-period, One Sequence, Multiple Dose, Crossover Study, A Study to Investigate Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2010
At a glance
- Drugs Ertapenem (Primary) ; Valproic acid (Primary)
- Indications Bacterial infections; Bipolar disorders; Community-acquired pneumonia; Epilepsy; Intra-abdominal infections; Migraine; Obstetric and gynaecological infections; Skin and soft tissue infections; Urinary tract infections
- Focus Pharmacokinetics
- 30 Nov 2010 Primary endpoints (maximum plasma concentration at steady state, area under the concentration versus time curve) added as reported by ClinicalTrials.gov.
- 26 Feb 2010 New trial record